Hanson R N, Franke L A, Kaplan M
Department of Medicinal Chemistry, College of Pharmacy and Allied Health Professions, Northeastern University, Boston, MA 02115.
Int J Rad Appl Instrum B. 1990;17(2):239-45. doi: 10.1016/0883-2897(90)90153-r.
A series of three 125I-labeled 17 alpha-iodovinylestradiol derivatives previously demonstrated to have a selectivity for estrogen receptor tissues in immature female rats were selected for further evaluation in adult female rats. In normal adult female rats, the iodovinyl analogs of moxestrol (IV beta ME2), and moxestrol-3-O methyl ether (IV beta ME2-3-OMe) demonstrated high uterine uptake (0.296-0.437 and 0.135-0.199%ID-kg/g) and selectivity (10-18:1) over the 6 h time period. Subsequent evaluation in two tumor models indicated that [125I]V beta ME2 also possessed the highest tumor uptake and selectivity in the adult female rats bearing the estrogen responsive 9,10-dimethyl-1,2-benzanthracene(DMBA)-induced mammary tumors and that this was receptor mediated. An estrogen independent tumor, the transplanted Walker 256 mammary adenocarcinoma, showed no selectivity of radioligand uptake compared with nontarget tissues. The results suggest the applicability of this agent to the in vivo detection and characterization of estrogen responsive tumors in man.
先前已证明,一系列三种125I标记的17α-碘乙烯基雌二醇衍生物对未成熟雌性大鼠的雌激素受体组织具有选择性,现选择这些衍生物在成年雌性大鼠中进行进一步评估。在正常成年雌性大鼠中,莫昔司汀的碘乙烯基类似物(IVβME2)和莫昔司汀-3-O甲基醚(IVβME2-3-OMe)在6小时时间段内显示出高子宫摄取率(0.296 - 0.437和0.135 - 0.199%ID-kg/g)和选择性(10 - 18:1)。在两种肿瘤模型中的后续评估表明,[125I]VβME2在携带雌激素反应性9,10-二甲基-1,2-苯并蒽(DMBA)诱导的乳腺肿瘤的成年雌性大鼠中也具有最高的肿瘤摄取率和选择性,且这是受体介导的。一种雌激素非依赖性肿瘤,即移植的Walker 256乳腺腺癌,与非靶组织相比,未显示出放射性配体摄取的选择性。结果表明该试剂适用于人体雌激素反应性肿瘤的体内检测和表征。